BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 18606689)

  • 1. The absence of lymphoid CD8+ dendritic cell maturation in L-selectin-/- respiratory compartment attenuates antiviral immunity.
    Pascual DW; Wang X; Kochetkova I; Callis G; Riccardi C
    J Immunol; 2008 Jul; 181(2):1345-56. PubMed ID: 18606689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced suppression of polyclonal CD8
    Mu C; Zhang X; Wang L; Xu A; Ahmed KA; Pang X; Chibbar R; Freywald A; Huang J; Zhu Y; Xiang J
    J Leukoc Biol; 2017 May; 101(5):1221-1231. PubMed ID: 28096300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced effector and memory CTL responses generated by incorporation of receptor activator of NF-kappa B (RANK)/RANK ligand costimulatory molecules into dendritic cell immunogens expressing a human tumor-specific antigen.
    Wiethe C; Dittmar K; Doan T; Lindenmaier W; Tindle R
    J Immunol; 2003 Oct; 171(8):4121-30. PubMed ID: 14530334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The duration of signaling through CD40 directs biological ability of dendritic cells to induce antitumor immunity.
    Watanabe S; Kagamu H; Yoshizawa H; Fujita N; Tanaka H; Tanaka J; Gejyo F
    J Immunol; 2003 Dec; 171(11):5828-36. PubMed ID: 14634092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TACI-BLyS signaling via B-cell-dendritic cell cooperation is required for naive CD8+ T-cell priming in vivo.
    Diaz-de-Durana Y; Mantchev GT; Bram RJ; Franco A
    Blood; 2006 Jan; 107(2):594-601. PubMed ID: 16195331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipopolysaccharide modulation of dendritic cells is insufficient to mature dendritic cells to generate CTLs from naive polyclonal CD8+ T cells in vitro, whereas CD40 ligation is essential.
    Kelleher M; Beverley PC
    J Immunol; 2001 Dec; 167(11):6247-55. PubMed ID: 11714787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation.
    Fujii S; Liu K; Smith C; Bonito AJ; Steinman RM
    J Exp Med; 2004 Jun; 199(12):1607-18. PubMed ID: 15197224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation.
    Grohmann U; Bianchi R; Orabona C; Fallarino F; Vacca C; Micheletti A; Fioretti MC; Puccetti P
    J Immunol; 2003 Sep; 171(5):2581-7. PubMed ID: 12928409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient antigen gene transduction using Arg-Gly-Asp fiber-mutant adenovirus vectors can potentiate antitumor vaccine efficacy and maturation of murine dendritic cells.
    Okada N; Saito T; Masunaga Y; Tsukada Y; Nakagawa S; Mizuguchi H; Mori K; Okada Y; Fujita T; Hayakawa T; Mayumi T; Yamamoto A
    Cancer Res; 2001 Nov; 61(21):7913-9. PubMed ID: 11691812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance.
    Bonifaz L; Bonnyay D; Mahnke K; Rivera M; Nussenzweig MC; Steinman RM
    J Exp Med; 2002 Dec; 196(12):1627-38. PubMed ID: 12486105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential delivery of maturation stimuli increases human dendritic cell IL-12 production and enhances tumor antigen-specific immunogenicity.
    Kalady MF; Onaitis MW; Emani S; Abdel-Wahab Z; Tyler DS; Pruitt SK
    J Surg Res; 2004 Jan; 116(1):24-31. PubMed ID: 14732346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of dendritic cells that cross-present tumor-derived antigen licenses CD8+ CTL to cause tumor eradication.
    van Mierlo GJ; Boonman ZF; Dumortier HM; den Boer AT; Fransen MF; Nouta J; van der Voort EI; Offringa R; Toes RE; Melief CJ
    J Immunol; 2004 Dec; 173(11):6753-9. PubMed ID: 15557168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Provision of 4-1BB ligand enhances effector and memory CTL responses generated by immunization with dendritic cells expressing a human tumor-associated antigen.
    Wiethe C; Dittmar K; Doan T; Lindenmaier W; Tindle R
    J Immunol; 2003 Mar; 170(6):2912-22. PubMed ID: 12626542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The subcellular location of antigen expressed by adenoviral vectors modifies adaptive immunity but not dependency on cross-presenting dendritic cells.
    Henning P; Gustafsson T; Flach CF; Hua YJ; Strömbeck A; Holmgren J; Lindholm L; Yrlid U
    Eur J Immunol; 2011 Aug; 41(8):2185-96. PubMed ID: 21538977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and cellular requirements for enhanced antigen cross-presentation to CD8 cytotoxic T lymphocytes.
    Oizumi S; Strbo N; Pahwa S; Deyev V; Podack ER
    J Immunol; 2007 Aug; 179(4):2310-7. PubMed ID: 17675492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactobacilli secreting a tumor antigen and IL15 activates neutrophils and dendritic cells and generates cytotoxic T lymphocytes against cancer cells.
    Kandasamy M; Bay BH; Lee YK; Mahendran R
    Cell Immunol; 2011; 271(1):89-96. PubMed ID: 21723537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated CD40 ligand gene-engineered dendritic cells elicit enhanced CD8(+) cytotoxic T-cell activation and antitumor immunity.
    Liu Y; Zhang X; Zhang W; Chen Z; Chan T; Ali K; Jia Z; Xiang J
    Cancer Gene Ther; 2002 Feb; 9(2):202-8. PubMed ID: 11857039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens.
    Kaplan JM; Yu Q; Piraino ST; Pennington SE; Shankara S; Woodworth LA; Roberts BL
    J Immunol; 1999 Jul; 163(2):699-707. PubMed ID: 10395660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late dendritic cells are still able to evoke a potent alloreactive CTL response.
    Repnik U; Bergant M; Wraber B; Jeras M
    Immunobiology; 2008; 213(1):51-64. PubMed ID: 18207027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Segregation of mechanisms for cytotoxic T lymphocyte killing between lungs and regional lymph nodes subsequent to intratracheal delivery of adenovirus 2 vector.
    Wang X; Hillemeyer P; Pascual DW
    Viral Immunol; 2003; 16(4):525-39. PubMed ID: 14733739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.